Annual ROE
1.24%
-93.16%-98.69%
31 December 2023
Summary:
Bellevue Life Sciences Acquisit annual return on equity is currently 1.24%, with the most recent change of -93.16% (-98.69%) on 31 December 2023. During the last 3 years, it has fallen by -155.90% (-99.21%). BLACU annual ROE is now -99.21% below its all-time high of 157.14%, reached on 01 December 2021.BLACU ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-2.00%
-1.56%-354.55%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit quarterly return on equity is currently -2.00%, with the most recent change of -1.56% (-354.55%) on 30 September 2024. Over the past year, it has dropped by -2.92% (-317.39%). BLACU quarterly ROE is now -100.89% below its all-time high of 224.48%, reached on 01 September 2022.BLACU Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLACU ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -98.7% | -317.4% |
| 3 y3 years | -99.2% | -101.3% |
| 5 y5 years | - | - |
BLACU ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -99.2% | at low | -100.9% | at low |
| 5 y | 5 years | -99.2% | +100.0% | -100.9% | at low |
| alltime | all time | -99.2% | +100.0% | -100.9% | at low |
Bellevue Life Sciences Acquisit ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -2.00%(+354.5%) |
| June 2024 | - | -0.44%(-195.7%) |
| Mar 2024 | - | 0.46%(-32.4%) |
| Dec 2023 | 1.24%(-98.7%) | 0.68%(-26.1%) |
| Sept 2023 | - | 0.92%(-16.4%) |
| June 2023 | - | 1.10%(+150.0%) |
| Mar 2023 | - | 0.44% |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | 94.40%(-39.9%) | - |
| Dec 2022 | - | 165.94%(-26.1%) |
| Sept 2022 | - | 224.48%(+296.6%) |
| June 2022 | - | 56.60%(-62.9%) |
| Mar 2022 | - | 152.38%(+3.2%) |
| Dec 2021 | 157.14%(-100.0%) | 147.62% |
| Dec 2020 | -3.91 M% | - |
FAQ
- What is Bellevue Life Sciences Acquisit annual return on equity?
- What is the all time high annual ROE for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit annual ROE year-on-year change?
- What is Bellevue Life Sciences Acquisit quarterly return on equity?
- What is the all time high quarterly ROE for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly ROE year-on-year change?
What is Bellevue Life Sciences Acquisit annual return on equity?
The current annual ROE of BLACU is 1.24%
What is the all time high annual ROE for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high annual return on equity is 157.14%
What is Bellevue Life Sciences Acquisit annual ROE year-on-year change?
Over the past year, BLACU annual return on equity has changed by -93.16% (-98.69%)
What is Bellevue Life Sciences Acquisit quarterly return on equity?
The current quarterly ROE of BLACU is -2.00%
What is the all time high quarterly ROE for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high quarterly return on equity is 224.48%
What is Bellevue Life Sciences Acquisit quarterly ROE year-on-year change?
Over the past year, BLACU quarterly return on equity has changed by -2.92% (-317.39%)